Lonnie Bookbinder, MBA, PhD
CEO, Board Chairman
Leadership in pharma industry, drug licensing to pharma, serial entrepreneur, 47 years in industry
President Prolong Pharma, raised $300M, 3 IPOs, and Inventor of PEGylation.
Mark Kester, PhD
Director of Nanotech Center & Pharmacology Professor at U. VA, Drug Delivery Systems; co-founder Keystone Nano
Narendra Vaish, PhD
Chief Scientific Officer, Board Member
Expert in RNA Inhibition and siRNA drug design with >100 biomed patents– also our patent agent.
Brad Niles, PhD
Chief Operating Officer, VP R&D
Managed Oncology Labs at UCD/Industry, expert in drug discovery, in-vitro assays, and IP
Gary Hooper, MBA
Chief Business Officer, VP Corporate Development
Ex Pharma/Genentech, CEO Multiple biotech firms, expertise in licensing to pharmaceutical companies
Chief Financial Officer & VP of Communications
Honor Degree: Finance, expertise in fundraising, entrepreneurship, investor relations, & communications
Nicole Nuñez, PhD
Expert in cancer molecular biology, + medicinal chem.